There is growing evidence that not only the novel coronavirus disease (COVID‐19) but also
the COVID‐19 vaccines can cause a variety of skin reactions. In this review article, we …

Autoimmunity linked to COVID-19 immunization has been recorded throughout the
pandemic. Herein we present six new patients who experienced relapses of previous …

Background Cases of severe autoimmune blistering diseases (AIBDs) have recently been
reported in association with the severe acute respiratory syndrome coronavirus 2 (SARS …

Bullous pemphigoid (BP) is an autoimmune bullous disease caused by circulating
autoantibodies toward the hemidesmosomal antigens BP180 and BP230. Cases of BP have …

Although vaccination is widely accepted as an effective method of preventing and controlling
the COVID‐19 pandemic, many people are concerned about possible cutaneous side …

3 Tanaka Y, Mimori T, Yamanaka H et al. Effectiveness and safety of initiating adalimumab
plus≥ 12 mg/week methotrexate with adjustable dosing in biologic-naıve patients with early …

Abstract Coronavirus disease 2019 (COVID-19) is a real challenge for humanity with high
morbidity and mortality. Despite being primarily a respiratory illness, COVID-19 can affect …

The outbreak of coronavirus disease 2019 (COVID-19) represented a new worldwide
challenge, strongly impacting on the global economy, overall health and lifestyle. Since …

Autoimmune bullous diseases (AIBDs) are a heterogeneous group of diseases
characterized by cutaneous and mucosal vesicles, blisters, and erosions. Several factors …

FIGURE 1 (a, b) Histopathological images (hematoxylin–eosin).(a) Subepidermal bulla
(original magnification× 5) and (b) vacuolar degeneration at the epidermis− dermis junction …